These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7330795)

  • 41. [Sputum consistency in miners suffering from chronic bronchitis and pneumoconiosis].
    Turczyński B; Kossmann S; Bednarski W; Pilarek M
    Pneumonol Pol; 1978 Jan; 46(1):19-24. PubMed ID: 628617
    [No Abstract]   [Full Text] [Related]  

  • 42. Pharmacokinetics of metronidazole in saliva.
    Mustofa ; Suryawati S; Santoso B
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):474-8. PubMed ID: 1813432
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [In vitro antibacterial activity and pharmacokinetics of ofloxacin in chronic respiratory tract infections].
    Sugimoto Y; Matsumoto Y; Hitsuda Y; Yamamoto Y; Ishitobi K; Sasaki T
    Jpn J Antibiot; 1987 Feb; 40(2):325-30. PubMed ID: 3474429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative effectiveness of tetracycline, minocycline and doxycycline in treatment of acute-on-chronic bronchitis. A study based on sputum levels.
    Ruhen RW; Tandon MK
    Med J Aust; 1976 Feb; 1(6):151-3. PubMed ID: 1083475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amoxycillin levels in sputum, serum, and saliva.
    Stewart SM; Anderson IM; Jones GR; Calder MA
    Thorax; 1974 Jan; 29(1):110-4. PubMed ID: 4545190
    [No Abstract]   [Full Text] [Related]  

  • 46. Role of chronic Pseudomonas aeruginosa infection in airway mucosal permeability.
    Ishihara H; Honda I; Shimura S; Sasaki H; Takishima T
    Chest; 1991 Dec; 100(6):1607-13. PubMed ID: 1959404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dirithromycin concentrations in bronchial mucosa and secretions.
    Leroyer C; Muller-Serieys C; Quiot J; Benhamou D; Clavier J; Bergogne-Bérézin E
    Respiration; 1998; 65(5):381-5. PubMed ID: 9782221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cefaclor therapy in acute exacerbations of chronic bronchitis.
    Wernstedt L; Berntsson E; Thiringer G
    Postgrad Med J; 1979; 55 Suppl 4():56-8. PubMed ID: 548943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuraminic acid content of sputum in chronic bronchitis.
    Keal EE; Reid L
    Thorax; 1972 Nov; 27(6):643-53. PubMed ID: 4647626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    DeAbate CA; Bettis R; Munk ZM; Fleming H; Munn NJ; Riffer E; Bagby B; Giguere G; Collins JJ
    Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The change of concentration of endothelin derived from alveolar macrophages and in induced sputum in patients with chronic bronchitis].
    Peng H; Chen P; Cai S
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun; 24(6):351-4. PubMed ID: 11802988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sputum neutrophilia can mask eosinophilic bronchitis during exacerbations.
    D'silva L; Allen CJ; Hargreave FE; Parameswaran K
    Can Respir J; 2007; 14(5):281-4. PubMed ID: 17703243
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bacampicillin twice daily: a dose-response study in acute exacerbations of chronic bronchitis.
    Maesen FP; Davies BI; Sjövall J
    Eur J Respir Dis; 1981 Dec; 62(6):434-40. PubMed ID: 7347694
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brodimoprim concentrations in bronchial mucosa, bronchial secretions and middle ear effusions.
    Scaglione F; Cogo R; Pintucci JP; Demartini G; Dugnani S; Maccarinelli G; Fraschini F
    J Chemother; 1993 Dec; 5(6):490-3. PubMed ID: 8195843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?
    Rovina N; Papapetropoulos A; Kollintza A; Michailidou M; Simoes DC; Roussos C; Gratziou C
    Respir Res; 2007 Jul; 8(1):53. PubMed ID: 17631682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum and sputum alpha 2 macroglobulin in patients with chronic obstructive airways disease.
    Burnett D; Stockley RA
    Thorax; 1981 Jul; 36(7):512-6. PubMed ID: 6171904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cefoxitin and cefuroxim concentrations after intravenous administration in sputum of patients with chronic bronchitis (author's transl)].
    Zimmermann I; Ruhe W; Ritzerfeld W; Ulmer WT
    Immun Infekt; 1979 Apr; 7(2):52-6. PubMed ID: 457189
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The mechanism of airway inflammation in eosinophilic bronchitis and cough variant asthma].
    Wang JL; Ren ZY; Xia JB; Huang S; Qi MH; Wang LM; Ye J
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):433-7. PubMed ID: 21781515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in the fibre system and viscosity of the sputum of bronchitis during treatment with bromhexine and guaiphenesin (guaiacol glyceryl ether).
    Bürgi H
    Scand J Respir Dis Suppl; 1974; 90():81-5. PubMed ID: 4618378
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacokinetics of Sobrerol in chronic bronchitis. Comparison of serum and bronchial mucus levels.
    Braga PC; De Angelis L; Bossi R; Scaglione F; Scarpazza G; Allegra L; Fraschini F
    Eur J Clin Pharmacol; 1983; 24(2):209-15. PubMed ID: 6840169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.